ClinicalTrials.gg
RecruitingNCT07492745REMOTIVEUpdated Oct 7, 2026

Effect of Using a Reminder to Encourage Patients to be Active During Their Hospital Stay.

An interventional study of Vibrating reminder and Control group in Inpatients and Frail, sponsored by Groupe Hospitalier du Havre. Recruiting at 4 sites in 2 countries. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Primary conditionMotor Activity(the registry's first term)UnverifiedIs this wrong?Motor Activity is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Groupe Hospitalier du Havre · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

Around 30% of patients aged 65 and over experience functional decline due to hospitalization. Physical inactivity, often without medical justification, is common during hospital stays.This immobility leads to loss of autonomy, muscle strength, and increases post-discharge risks.

Slow walking for 25-40 minutes daily significantly improves functional capacity. However, it could be difficult to reach this time of walking due to a lack of physiotherapist in hospital.

A vibrating watch may encourage patients to walk or perform strengthening exercises. This simple intervention aims to improve function without requiring additional staff or resources

Read the detailed description

30% of patients aged 65 or older will experience a decline in functional capacity as a result of hospitalization.

Illness and hospitalization increase sedentary behavior in patients. It is common for patients to spend long periods of time resting in bed, regardless of their primary reason for admission. During hospitalization, nearly 60% of episodes of bed rest have no documented medical indications. Low physical activity during hospitalization can lead to impaired independence, loss of muscle strength, and decreased functional capacity. These losses in frail individuals are associated with increased disability and lead to a critical 30-day period after hospital discharge that exacerbates deconditioning. This period of increasing functional vulnerability can lead to readmission to hospital, disability, institutionalization, morbidity, and early mortality.

The results of a meta-analysis show that walking slowly for about 25-40 minutes per day is sufficient to improve patients' functional capacity during hospitalization. The organization of care to promote patient mobility must be reviewed to make patients more involved in their care and more independent.

It has been demonstrated for some time that the use of a reminder system (e.g., alarm) is a factor that promotes increased patient adherence to their treatments. The advantage of a vibrating reminder is that it is simple to use, very inexpensive, easy to implement in all hospital wards, and does not require additional human resources.

The main hypothesis of this study is that the use of a vibrating watch set to 6 reminders per day to prompt patients to perform muscle strengthening exercises or walk a distance determined by the rehabilitation professional will increase patients' functional capacity.

02

Conditions studied

  • Inpatients
  • Frail

Browse trials for

Keywords

  • inpatients
  • physical activity
  • reminder device
  • frailty
  • functional independancy
03

In context

Motor Activity Unverified

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

This study's planned enrollment of 204 is above the median of 60 across 8,412 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Groupe Hospitalier du Havre is the lead sponsor of 22 studies on the registry; 6 are open to participants now.

Compared within Motor Activity, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 50 or over with a score of 4 or above on the Clinical Frailty Scale (vulnerable but not dependent patients, symptoms limiting activities, patients who are slower/more fatigued).
  • Must be able to get up from a chair without assistance.
  • Patients must be able to communicate with staff, understand instructions, give consent, and cooperate with staff.

Exclusion criteria

Exclusion Criteria:

  • Patients with an estimated hospital stay of less than 5 days.
  • to physical activity determined by the medical team (e.g., cardiovascular instability, orthopedic contraindications, etc.).
  • Terminal illness.
  • Patients scheduled for surgery.
  • Pregnant women.
  • People who do not understand French.
  • People protected under the law.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
204 participants (estimated)

Study arms

  • Experimental
    Intervention

    Regardless of randomization, the physiotherapist will be able to provide the patient with the usual care, such as walking, muscle strengthening exercises, and respiratory physiotherapy if necessary. Self-rehabilitation exercises will be given to the patient, who will have to perform them independently. The exercises will be prescribed according to the patient's physical abilities and environmental constraints. A vibrating reminder will be given to the patient, set to go off six times a day. The patient will be required to perform the prescribed exercises each time the vibrating alarm goes off. Six vibrating reminders per day will be sent in the hope that the patient will be active at least three times a day, taking into account various constraints (visits, medical care, examinations, fatigue).

    Device: Vibrating reminder

  • Sham comparator
    control

    In the control group, the physiotherapist will perform the usual treatments and apply the protocol described above in the experimental group, but will set the vibrating watch, to go off once a day. The patient will be advised to perform the exercises every hour independantly.

    Device: Control group

Interventions

  • DeviceVibrating reminder

    The exercises will be prescribed according to the patient's physical abilities and environmental constraints. A vibrating reminder will be given to the patient, set to go off six times a day.

  • DeviceControl group

    The exercises will be prescribed according to the patient's physical abilities and environmental constraints. A vibrating reminder will be given to the patient, set to go off once time a day.

    Also known as: usual care

06

What researchers measure

Primary outcomes

  1. SPPB

    The SPPB (Short Physical Performance Battery) is the sum of scores on three criteria: the balance test, the walking speed test, and the chair rise test. This test assesses an individual's physical performance. The score ranges from 0 (lowest) to 12 (highest). The magnitude of change considered clinically relevant for the SPPB is 1 point.

    Time frame: Within 24 hours of admission and within 48 hours prior to discharge from hospital.

Secondary outcomes

  1. Volume and intensity of physical activity

    The number of steps per day and the number of movements per minute will be measured.An accelerometer will be placed on the wrist of the non-dominant limb. Data will be measured 24 hours a day.

    Time frame: Within 24 hours of admission and within 48 hours prior to discharge from hospital.

  2. functional independancy

    Will be measured using the Barthel Index, based on the patient's level of independancy during the week prior to hospitalization and upon discharge from the hospital. The Barthel Index assesses a person's ability to perform ten essential activities of daily living.

    Time frame: Within 24 hours of admission and within 48 hours prior to discharge from hospital.

  3. Patient compliance to the prescribed exercises

    Compliance will be measured using a compliance record sheet. This will enable us to note whether the exercises have been performed, and if so, the number of times per day, the schedule, the type, the reason for interruption, and whether or not there has been any pain, rated from 0 to 10.

    Time frame: Within 24 hours of baseline and within 48 hours prior to discharge from hospital

  4. falls

    number of falls during hospitalization

    Time frame: Within 24 hours of baseline and within 48 hours prior to discharge from hospital ; and at 3 months after discharge.

  5. Volume and type of rehabilitation in-hospital

    performed by physiotherapist

    Time frame: Within 24 hours of baseline and within 48 hours prior to discharge from hospital

  6. The volume and location of rehabilitation

    performed by rehabilitation professionals after discharge

    Time frame: at 3 months after discharge

  7. Health-related Quality of life

    mesured by EuroQol(5-5). It assesses quality of life according to five main dimensions: mobility, independence, daily activities, pain and discomfort, anxiety, and depression. Each dimension is assessed on a five-point severity scale. The score ranges from 0 to 100 (best possible health)

    Time frame: 24 hours after admission, 48 hours before discharge, and 3 months after hospitalization

07

Study locations

1 of 4 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data type : deidentified participant data

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Start date : after publication End date : 15 years after publication

Access criteria: the request shall be sent to Guillaume Prieur : guillaume.prieur@ch-havre.fr

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Oct 2028, 34 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 34 months is above that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 19, 2026
First posted
Mar 25, 2026
StartActual
Nov 19, 2025
Primary completionEst.
Oct 1, 2028
CompletionEst.
Jan 1, 2029
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: identifiers and verification date
1 update, last Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Minor edits only
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07492745
Lead sponsor
Groupe Hospitalier du Havre
Collaborators
Centre Hospitalier de Valence, Centre Hospitalier of Chartres
Responsible party
Sponsor
First posted
Mar 25, 2026
Start date
Nov 19, 2025
Primary completion
Oct 1, 2028 (estimated)
Completion
Jan 1, 2029 (estimated)
Last update
Oct 7, 2026

Study contacts

Guillaume Prieur, PT, PhD
Contact
guillaume.prieur@ch-havre.fr
+33630038824
Yann Combret, PT, PhD
Contact
yann.combret@ch-havre.fr
+33686327255
Léa Bansard, PT, MSc
principal investigator · Groupe Hospitalier du Havre
Guillaume Prieur, PT, PhD
principal investigator · Groupe Hospitalier du Havre
Yann Combret, PT, PhD
study director · Groupe Hospitalier du Havre
Clément Medrinal, Prof.
study chair · Groupe Hospitalier du Havre

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion